Death by Clot: Hematology Assessment, Pathophysiology & Pharmacology
Hematologic disorders are a leading cause of admission, mortality and morbidity in the acute patient population. Most hospitalized patients are at risk for either bleeding or clotting.
This course will offer a comprehensive review of the physiology and assessment of the hematopoietic system. The function and pathologies related to red cells, white cells and platelets and clinical application of the interpretation of the complete blood count, and coagulation profiles will be outlined.
Specific disorders discussed include: disseminated intravascular coagulation (DIC), sickle cell disease, hemophilia, heparin induced thrombocytopenia (HIT), idiopathic thrombocytopenic purpura (ITP), hemolysis elevated liver enzymes and low platelets (HELLP), and von Willebrand's disease. Hypercoagulable states and clotting disorders such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and acute coronary syndrome (ACS) will be evaluated. Pathology, assessment, treatment options, clinical guidelines and evidence based practice will be discussed.
Program Objectives
- Explain hematology assessment including the CBC and coagulation profiles
- Discuss human and synthetic blood transfusions: Friend or Foe?
- Recognize clinical indications and assessment of common hematology drugs- anticoagulants and antiplatelets
- Describe the clinical implications and treatment options for common clotting and bleeding disorders seen in acute care practice
If you experience any technical issues, please let us know by emailing helpdesk3-3333@stanfordhealthcare.org or call 650-723-3333.
- Documents used in this program are intended for use by participants only.
- No representations or warranties are made for outside use.
- Not for outside reproductions or publications without permission from faculty.
Due to copyright regulations and protecting Patient Health Information (PHI), some of the slides may not contain the pictures as seen in class.